Sort
21,453 grants matching “tuberculosis”
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$609,027Jennifer A Philips · Washington University · R01 · FY2024 · AI
MACAQUE MODEL OF AIDS VIRUS-RELATED PULMONARY TUBERCULOS
$609,000Beth Israel Deaconess Medical Center · R01 · FY2001 · HL
MACAQUE MODEL OF AIDS VIRUS-RELATED PULMONARY TUBERCULOS
$609,000Beth Israel Deaconess Medical Center · R01 · FY2002 · HL
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment
$608,967Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · HL
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development
$608,952Delphi Chatterjee · Colorado State University · R01 · FY2018 · AI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
$608,927Susan E Dorman · Johns Hopkins University · R01 · FY2010 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$608,599Robert Lee Brawley · Ky St Cabinet/Health/Family Services · U52 · FY2013 · PS
Mycobacterium tuberculosis environmental signal integration: single cell in vivo understanding of its influence on infection heterogeneity and treatment efficacy
$608,397Shumin Tan · Tufts University Boston · R01 · FY2021 · AI
Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
$608,327Sarit A Golub · Hunter College · R01 · FY2015 · AA
Mycobacterium tuberculosis environmental signal integration: single cell in vivo understanding of its influence on infection heterogeneity and treatment efficacy
$608,229Shumin Tan · Tufts University Boston · R01 · FY2020 · AI
Minimizing in vivo Drug Tolerance induction in tuberculosis.
$608,113David G Russell · Rbhs-New Jersey Medical School · U19 · FY2021 · AI
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
$608,102Volker Briken · Univ Of Maryland, College Park · R01 · FY2021 · AI
DIRECTLY ADMINISTERED HIV THERAPY IN METHADONE CLINICS
$608,055Gregory M Lucas · Johns Hopkins University · R01 · FY2008 · DA
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$608,042Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$607,999Joshua William Schaeffer · Colorado State University · R01 · FY2023 · OH
The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF Antagonist
$607,957Jennifer C Felger · Emory University · R01 · FY2022 · MH
Epidemiology of multidrug-resistant tuberculosis in Peru
$607,867Mercedes C Becerra · Harvard Medical School · U01 · FY2010 · AI
Epidemiology of multidrug-resistant tuberculosis in Peru
$607,865Mercedes C Becerra · Harvard Medical School · U01 · FY2009 · AI
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
$607,857Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · HL
Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa
$607,835Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2021 · AI
DAIDS and DTBE Partnership for TB and TB/HIV Research
$607,800National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
ARKANSAS TUBERCULOSIS CONTROL PROGRAM
$607,747Naveen Patil · Arkansas State Department Of Health · U52 · FY2011 · PS
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis
$607,711Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2014 · AI
Coronary Atherosclerosis and Immune Activation in HIV and Tuberculosis Infection
$607,624Moises Arturo Huaman Joo · University Of Cincinnati · R01 · FY2024 · HL
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana
$607,604Robert Gross · University Of Pennsylvania · R01 · FY2022 · DA